A Phase 1 Dose Escalation With Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMV564 Alone and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
Associated ConditionsMultiple Tumor Types
The purpose of this clinical research study is to learn more about the safety of AMV564, and to learn how AMV564 affects your cancer-specific cells and other blood cells. In addition, the study will look at how long AMV564 can be measured in your blood to better understand how your body processes AMV564.
This study is currently enrolling.